Laboratory tests revealed elevated inflammatory markers (C-reactive protein (CRP) 55.6 mg/L, reference range (RR) < 3.0), elevated aminotransferase activity (alanine aminotransferase (ALT) 727 U/L, RR 12–78, aspartate aminotransferase (AST) 717 U/L, RR < 50), and features of cholestasis (g-glutamyl transferase (GGTP) 364 U/L, RR 4–22, alkaline phosphatase (ALP) 536 U/L, RR < 362, and direct bilirubin 0.34 mg/dL,RR 0.0–0.2). This evidence concerns the gene GPT and cholestasis.